Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 26.60
-0.55 (-2.03%)
Feb 21, 2025, 5:04 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 615.00 million as of February 21, 2025. Its market cap has decreased by -53.50% in one year.
Market Cap
615.00M
Enterprise Value
448.39M
Revenue
91.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.60
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 615.00M, an increase of 988.43%. That is a compound annual growth rate of 19.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.62B |
| Synektik Spólka Akcyjna | 1.95B |
| Voxel | 1.51B |
| Celon Pharma | 1.21B |
| Selvita | 905.84M |
| Centrum Medyczne ENEL-MED | 565.61M |
| Scope Fluidics | 485.76M |
| Mercator Medical | 468.98M |